Abiopharma

New Form S-1/A - BIOVIE INC. Filed: 2025-07-22 AccNo: 0001520138-25-000216 Size: 8 MB

New Form 6-K - SciSparc Ltd. Filed: 2025-07-22 AccNo: 0001213900-25-066350 Size: 22 KB

New Form 8-K - Microbot Medical Inc. Filed: 2025-07-22 AccNo: 0001641172-25-020524 Size: 237 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-07-22 AccNo: 0001628280-25-035506 Size: 203 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item …

New Form 8-K - Replimune Group, Inc. Filed: 2025-07-22 AccNo: 0001104659-25-069489 Size: 208 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - Concord Medical Services Holdings Ltd Filed: 2025-07-22 AccNo: 0001104659-25-069487 Size: 13 KB

New Form 424B5 - Imunon, Inc. Filed: 2025-07-22 AccNo: 0001641172-25-020519 Size: 24 KB

New Form 4 - GALECTIN THERAPEUTICS INC Filed: 2025-07-22 AccNo: 0001133416-25-000035 Size: 6 KB

New Form 6-K - Cardiol Therapeutics Inc. Filed: 2025-07-22 AccNo: 0001062993-25-013016 Size: 37 KB

New Form 8-K - Lantheus Holdings, Inc. Filed: 2025-07-22 AccNo: 0001193125-25-162233 Size: 162 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits